Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep S Dave

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|February 9, 2018
Id Proteins Suppress E2A-Driven Invariant Natural Killer T Cell Development prior to TCR SelectionSumedha Roy, Amanda J Moore, Cassandra Love, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2013
PAK1 mediates resistance to PI3K inhibition in lymphomasKatherine Walsh, Matthew S McKinney, Cassandra Love, et al.
Cancer|May 30, 2020
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphomaMichelle J Lee, Jean L Koff, Jeffrey M Switchenko, et al.
Cancer Research|April 27, 2011
HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesisZachary C Hartman, Xiao-Yi Yang, Oliver Glass, et al.
Plos Pathogens|May 19, 2018
Plasmodium parasite exploits host aquaporin-3 during liver stage malaria infectionDora Posfai, Kayla Sylvester, Anupama Reddy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomasMarta Cuadros, Sandeep S Dave, Elaine S Jaffe, et al.
Journal of Virology|April 13, 2012
The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cellsEleonora Forte, Raul E Salinas, Christina Chang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2020
Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from MalawiYuri Fedoriw, Sara Selitsky, Nathan D Montgomery, et al.
Blood|April 22, 2009
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphomaKieron Dunleavy, Stefania Pittaluga, Myron S Czuczman, et al.
Blood|November 22, 2008
Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targetingNancy S Longo, Patricia L Lugar, Sule Yavuz, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|February 9, 2018
Id Proteins Suppress E2A-Driven Invariant Natural Killer T Cell Development prior to TCR SelectionSumedha Roy, Amanda J Moore, Cassandra Love, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2013
PAK1 mediates resistance to PI3K inhibition in lymphomasKatherine Walsh, Matthew S McKinney, Cassandra Love, et al.
Cancer|May 30, 2020
Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphomaMichelle J Lee, Jean L Koff, Jeffrey M Switchenko, et al.
Cancer Research|April 27, 2011
HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesisZachary C Hartman, Xiao-Yi Yang, Oliver Glass, et al.
Plos Pathogens|May 19, 2018
Plasmodium parasite exploits host aquaporin-3 during liver stage malaria infectionDora Posfai, Kayla Sylvester, Anupama Reddy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomasMarta Cuadros, Sandeep S Dave, Elaine S Jaffe, et al.
Journal of Virology|April 13, 2012
The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cellsEleonora Forte, Raul E Salinas, Christina Chang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 22, 2020
Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from MalawiYuri Fedoriw, Sara Selitsky, Nathan D Montgomery, et al.
Blood|April 22, 2009
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphomaKieron Dunleavy, Stefania Pittaluga, Myron S Czuczman, et al.
Blood|November 22, 2008
Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targetingNancy S Longo, Patricia L Lugar, Sule Yavuz, et al.
Pageof 7